After years of weight loss drug shortages, the FDA is saying there’s now an adequate supply for most medications and they ...
5h
Barchart on MSNIs Amgen Stock a Buy, Sell, or Hold as Weight-Loss Drug Trials Kick Off?Amgen (AMGN) is a biotech company based in California. It specializes in developing treatments for cardiovascular conditions, ...
Altimmune said on Thursday that it plans to test its lead experimental obesity drug, pemvidutide, to potentially treat ...
6hon MSN
Compounding pharmacies will have to stop producing copycats of tirzepatide, the active ingredient in the blockbuster weight ...
Mehmet Oz will likely face questions during his confirmation hearing about his past support of expanding the Medicare ...
Viking Therapeutics eyes billion-dollar obesity drug markets with pivotal trials and major production deals. Read more about ...
Season three of The White Lotus is causing waves, especially for its uneasy female friend group. The three women at the ...
New research shows that extreme weight loss and weight gain significantly increase the risk of death in obese individuals with cardiovascular disease.
To the person who continues to comment about our bad experience at the Plant City Strawberry Festival, you didn’t pay $85 for ...
To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...
With GLP-1 weight loss comes muscle loss. Gyms and personal trainers are rising to the challenge to help people build it back ...
The challenge of the obesity epidemic is widespread and one that even pediatricians face constantly,” a Connecticut doctor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results